Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

SELL
$32.4 - $68.18 $219,672 - $462,260
-6,780 Reduced 25.17%
20,154 $1.37 Million
Q2 2022

Aug 05, 2022

SELL
$22.3 - $37.39 $25,199 - $42,250
-1,130 Reduced 4.03%
26,934 $861,000
Q4 2021

Feb 08, 2022

SELL
$24.9 - $40.26 $12,350 - $19,968
-496 Reduced 1.74%
28,064 $821,000
Q2 2021

Aug 10, 2021

SELL
$32.46 - $43.42 $1.6 Million - $2.13 Million
-49,152 Reduced 63.25%
28,560 $1 Million
Q1 2021

May 10, 2021

SELL
$38.94 - $50.85 $76,322 - $99,666
-1,960 Reduced 2.46%
77,712 $3.17 Million
Q4 2020

Feb 08, 2021

BUY
$37.65 - $63.77 $418,555 - $708,931
11,117 Added 16.22%
79,672 $3.45 Million
Q3 2020

Nov 09, 2020

BUY
$52.76 - $74.49 $220,536 - $311,368
4,180 Added 6.49%
68,555 $3.78 Million
Q2 2020

Aug 07, 2020

BUY
$48.73 - $81.82 $1.85 Million - $3.1 Million
37,926 Added 143.39%
64,375 $4.06 Million
Q4 2019

Feb 03, 2020

BUY
$45.7 - $81.86 $914 - $1,637
20 Added 0.08%
26,449 $2.1 Million
Q2 2019

Aug 05, 2019

BUY
$52.6 - $63.29 $60,490 - $72,783
1,150 Added 4.55%
26,429 $1.39 Million
Q1 2019

May 03, 2019

BUY
$39.99 - $53.48 $12,396 - $16,578
310 Added 1.24%
25,279 $1.34 Million
Q4 2018

Feb 01, 2019

BUY
$31.54 - $46.67 $35,640 - $52,737
1,130 Added 4.74%
24,969 $1.03 Million
Q3 2018

Oct 31, 2018

BUY
$38.0 - $51.1 $6,460 - $8,687
170 Added 0.72%
23,839 $906,000
Q2 2018

Aug 06, 2018

BUY
$38.7 - $50.15 $150,930 - $195,585
3,900 Added 19.73%
23,669 $1.07 Million
Q1 2018

May 04, 2018

BUY
$39.6 - $65.9 $43,560 - $72,490
1,100 Added 5.89%
19,769 $955,000
Q4 2017

Feb 01, 2018

BUY
$29.7 - $45.7 $27,027 - $41,587
910 Added 5.12%
18,669 $735,000
Q3 2017

Oct 31, 2017

BUY
$25.1 - $31.05 $445,750 - $551,416
17,759
17,759 $551,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.